This video discusses the clinical equivalence of BI 695501 (Cyltezo®; adalimumab-adbm) and adalimumab for rheumatoid arthritis - the VOLTAIRE-RA and extension studies.
Evidence for Rheumatoid Arthritis
Uveitis Cyltezo® (adalimumab-adbm)
Videos - Video Journal of Biomedicine
Evidence for Rheumatoid Arthritis
Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research
Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews
Cyltezo®, First and Only FDA-approved Interchangeable Biosimilar to Humira®, Now Commercially Available in the United States
Evidence for Crohn's Disease
Cyltezo (adalimumab): Uses, Side Effects, Dosage & Reviews
Home - Video Journal of Biomedicine
